Brain Structure, Neurotransmitters, and Behavior (7A)
Help Questions
MCAT Psychological and Social Foundations › Brain Structure, Neurotransmitters, and Behavior (7A)
In a pharmacology experiment, 26 participants received either a selective $5$-$\text{HT}_{2A}$ receptor agonist at a subhallucinogenic dose or placebo before completing a cognitive reappraisal task during fMRI. The agonist increased functional coupling between medial prefrontal cortex (mPFC) and amygdala during reappraisal trials and was associated with greater reduction in negative affect ratings. Which outcome is most consistent with the observed neurotransmitter effects?
Enhanced regulation driven by increased acetylcholine release in the spinal cord
Enhanced emotion regulation consistent with increased mPFC–amygdala coordination under serotonergic modulation
No effect on affect ratings because $5$-$\text{HT}_{2A}$ receptors are limited to the cerebellum
Reduced reappraisal efficacy because serotonergic signaling prevents prefrontal regulation of amygdala activity
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. Neurotransmitters influence behavior by affecting brain structures, which mediate responses. In this vignette, serotonin affects emotion regulation through the medial prefrontal cortex (mPFC) and amygdala. Choice B is correct because it accurately reflects the role of serotonergic modulation in enhancing mPFC-amygdala coordination. Choice A is incorrect because it misinterprets serotonergic signaling as preventing regulation, contrary to the observed improvements. When analyzing neurotransmitter effects, consider direct brain structure involvement and ensure conclusions align with observed data.
In a study of memory consolidation, 27 participants received a $\beta$-adrenergic antagonist before viewing emotionally negative and neutral images. Twenty-four hours later, recognition memory for negative images was selectively reduced in the drug group, while memory for neutral images was similar to placebo. Amygdala activation during encoding of negative images was reduced, but hippocampal activation during neutral encoding was unchanged. Which statement best explains the findings?
Selective impairment indicates hippocampus is unnecessary for memory of emotional images
Blocking norepinephrine increases amygdala activation, strengthening memory for negative images
The effect is best explained by dopamine blockade in the cerebellum affecting neutral memory
Blocking norepinephrine signaling reduces amygdala-related enhancement of emotional memory, selectively impairing consolidation of negative material
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. Neurotransmitters influence behavior by affecting brain structures, which mediate responses. In this vignette, norepinephrine affects emotional memory through the amygdala. Choice D is correct because it accurately reflects the role of norepinephrine blockade in impairing consolidation of negative material. Choice B is incorrect because it misinterprets blockade as increasing activation, opposite to reduced memory effects. When analyzing neurotransmitter effects, consider direct brain structure involvement and ensure conclusions align with observed data. Consider valence-specific enhancements in memory encoding.
Researchers administered a D2 receptor antagonist to 34 participants and then assessed effort-based decision making in a task requiring repeated choices between a low-effort/low-reward option and a high-effort/high-reward option. fMRI showed reduced nucleus accumbens activation during anticipation of high reward after drug administration, while amygdala activation to aversive images was unchanged. Participants chose the high-effort option less frequently. Which behavior change would be expected following neurotransmitter modulation?
Greater selection of high-effort options due to increased dopaminergic tone in the nucleus accumbens
Reduced willingness to expend effort for reward, consistent with decreased dopamine signaling in ventral striatum
Improved declarative memory encoding due to D2 blockade in the hippocampus
Enhanced fear conditioning due to increased dopamine release in the amygdala
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. Neurotransmitters influence behavior by affecting brain structures, which mediate responses. In this vignette, dopamine affects effort-based decision making through the nucleus accumbens. Choice B is correct because it accurately reflects the role of decreased dopamine signaling in reducing motivation for high-effort rewards. Choice A is incorrect because it misinterprets the D2 antagonist as increasing dopaminergic tone, opposite to its blocking effect. When analyzing neurotransmitter effects, consider direct brain structure involvement and ensure conclusions align with observed data. Always verify how receptor modulation alters signaling pathways in reward-related behaviors.
A study examined startle modulation in 24 participants after administration of a glycine receptor positive modulator. The drug increased inhibitory tone in brainstem circuits and reduced baseline startle magnitude to acoustic bursts. However, startle potentiation by conditioned threat cues (relative increase during threat vs safe) was unchanged, and amygdala activation to threat cues was similar across conditions. Which outcome is most consistent with the observed neurotransmitter effects?
Reduced baseline startle due to increased dopamine release in nucleus accumbens
Eliminated threat potentiation because glycine modulation primarily suppresses hippocampal memory encoding
Increased baseline startle because glycine reduces inhibition in brainstem circuits
Reduced baseline startle with preserved threat potentiation, consistent with enhanced inhibition in brainstem reflex pathways without altering amygdala-driven modulation
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. Neurotransmitters influence behavior by affecting brain structures, which mediate responses. In this vignette, glycine affects startle reflexes through brainstem circuits. Choice A is correct because it accurately reflects the role of enhanced glycine inhibition in reducing baseline startle while preserving amygdala modulation. Choice B is incorrect because it misinterprets glycine as reducing inhibition, contrary to its inhibitory enhancement. When analyzing neurotransmitter effects, consider direct brain structure involvement and ensure conclusions align with observed data.
In a rodent-inspired human analog task, 32 participants received a low-dose NMDA receptor antagonist before a contextual fear generalization test. fMRI showed reduced hippocampal pattern separation signals (lower differentiation between similar contexts) and increased generalization of fear ratings to safe contexts. Amygdala responses to the original threat context were unchanged. Which statement best explains the findings?
Reduced glutamatergic NMDA signaling in hippocampus is consistent with poorer context discrimination and broader fear generalization
Fear generalization is best explained by increased dopamine release in primary visual cortex
Unchanged amygdala responses imply hippocampus is not involved in contextual aspects of fear learning
NMDA antagonism increases hippocampal pattern separation, narrowing fear to the threat context
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. Neurotransmitters influence behavior by affecting brain structures, which mediate responses. In this vignette, glutamate affects fear generalization through the hippocampus. Choice A is correct because it accurately reflects the role of reduced NMDA signaling in impairing context discrimination. Choice B is incorrect because it misinterprets NMDA antagonism as increasing pattern separation, contrary to the broader generalization observed. When analyzing neurotransmitter effects, consider direct brain structure involvement and ensure conclusions align with observed data. Assess how receptor blockade influences synaptic plasticity in memory systems.
A lesion study compared 19 patients with focal damage to the basolateral amygdala (BLA) to 19 matched controls. During a fear-potentiated startle paradigm, patients showed reduced skin conductance responses to a conditioned stimulus and lower plasma epinephrine responses, while startle responses to loud noises without conditioning were preserved. The study also reported lower central release of corticotropin-releasing hormone but did not measure dopamine. Which statement best explains how the described brain structure influences behavior via neurotransmitter activity?
BLA damage selectively increases conditioned fear by enhancing serotonergic signaling in the hippocampus
BLA damage impairs unconditioned startle reflexes by reducing acetylcholine release at neuromuscular junctions
BLA damage disrupts associative threat learning, reducing downstream autonomic arousal that normally accompanies fear expression
BLA damage increases fear conditioning because epinephrine is the primary inhibitory neurotransmitter in cortex
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. Neurotransmitters influence behavior by affecting brain structures, which mediate responses. In this vignette, epinephrine affects fear expression through the basolateral amygdala (BLA). Choice D is correct because it accurately reflects the role of BLA in associative learning and downstream autonomic arousal. Choice B is incorrect because it misinterprets BLA damage as increasing fear via serotonergic changes, opposite to the reduced responses observed. When analyzing neurotransmitter effects, consider direct brain structure involvement and ensure conclusions align with observed data. Evaluate how lesions disrupt specific pathways without affecting unrelated reflexes.
A drug intervention study tested a nicotinic acetylcholine receptor (nAChR) agonist versus placebo in adults (n = 56) performing a sustained attention task with rare target stimuli. EEG-derived indices of attentional allocation were collected, and fMRI analyses focused on the thalamus and dorsolateral prefrontal cortex (DLPFC). Relative to placebo, the agonist increased target detection accuracy and was associated with increased thalamic activation during target presentation, with modest increases in DLPFC activation during sustained task periods. Which outcome is most consistent with the observed neurotransmitter effects and brain structure involvement?
Lower target detection because acetylcholine acts only at neuromuscular junctions and not in the CNS
Higher target detection driven primarily by decreased GABA activity in the cerebellum improving balance
Higher target detection consistent with enhanced cholinergic modulation of thalamic relay and frontoparietal attention networks
Lower target detection due to reduced thalamic sensory gating under increased cholinergic signaling
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. Neurotransmitters influence behavior by affecting brain structures, which mediate responses. In this vignette, acetylcholine affects sustained attention through the thalamus and DLPFC. Choice B is correct because it accurately reflects the role of enhanced acetylcholine in modulating thalamic relay and attention networks, improving target detection. Choice A is incorrect because it misinterprets increased cholinergic signaling as reducing thalamic gating, which would not explain higher detection accuracy. When analyzing neurotransmitter effects, consider direct brain structure involvement and ensure conclusions align with observed data.
Researchers tested whether enhancing serotonin (5-HT) signaling alters impulsive choice. Adults (n = 50) received either an acute selective serotonin reuptake inhibitor (SSRI) or placebo before performing a delay-discounting task (choices between smaller immediate rewards and larger delayed rewards). fMRI analyses focused on ventromedial prefrontal cortex (vmPFC) during valuation, and a peripheral biomarker index of central 5-HT tone was collected pre- and post-dose. Compared with placebo, the SSRI group showed higher 5-HT tone and increased vmPFC activation during evaluation of delayed rewards, along with fewer immediate-reward choices. Which behavior change would be expected following neurotransmitter modulation, most consistent with the described brain structure involvement?
More delayed-reward choices consistent with increased vmPFC engagement during future-oriented valuation under higher 5-HT tone
No change in choice behavior because 5-HT affects only spinal reflexes rather than cortical valuation
More immediate-reward choices due to increased norepinephrine signaling in the locus coeruleus driving arousal
Greater preference for immediate rewards due to reduced vmPFC valuation of delayed outcomes under increased 5-HT tone
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. Neurotransmitters influence behavior by affecting brain structures, which mediate responses. In this vignette, serotonin affects impulsive choice through the vmPFC. Choice B is correct because it accurately reflects the role of increased serotonin in enhancing vmPFC valuation of delayed rewards, leading to more patient choices. Choice A is incorrect because it misinterprets higher 5-HT as reducing vmPFC valuation, which opposes the observed increase in delayed choices. When analyzing neurotransmitter effects, consider direct brain structure involvement and ensure conclusions align with observed data.
Researchers examined the role of GABAergic inhibition in motor control using a within-subject design (n = 30). Participants received a single dose of a benzodiazepine (positive allosteric modulator of GABA-A receptors) or placebo on separate days before performing a finger-tapping sequence task requiring precise timing. fMRI analyses focused on the cerebellum and primary motor cortex (M1). Relative to placebo, benzodiazepine administration increased a peripheral index consistent with enhanced GABA-A activity, reduced cerebellar activation during error correction, and increased timing variability (worse precision). Which behavior change would be expected following neurotransmitter modulation, most consistent with the described brain structure involvement?
Worsened timing precision consistent with enhanced GABAergic inhibition dampening cerebellar contributions to fine-tuned motor adjustment
No effect on timing because GABA-A receptors are restricted to the peripheral nervous system
Improved timing precision due to reduced inhibitory tone allowing greater cerebellar error correction
Improved timing precision due to increased glutamate release in the hippocampus enhancing declarative memory for the sequence
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. Neurotransmitters influence behavior by affecting brain structures, which mediate responses. In this vignette, GABA affects motor timing through the cerebellum. Choice B is correct because it accurately reflects the role of enhanced GABAergic inhibition in dampening cerebellar adjustments, worsening timing precision. Choice A is incorrect because it misinterprets reduced inhibitory tone as the outcome, which contradicts the enhanced GABA-A activity and increased variability. When analyzing neurotransmitter effects, consider direct brain structure involvement and ensure conclusions align with observed data.
In a within-subject study, 28 participants received either a nicotinic acetylcholine receptor (nAChR) partial agonist or placebo before performing a sustained attention task with infrequent targets. EEG was recorded, and source localization emphasized right dorsolateral prefrontal cortex (dlPFC). The partial agonist increased target-evoked P300 amplitude and increased dlPFC source strength; behaviorally, hit rate increased with minimal change in false alarms. Which outcome is most consistent with the observed neurotransmitter and brain-structure effects?
Increased false alarms due to selective inhibition of GABA receptors in the cerebellum
Increased hit rate due to enhanced cholinergic modulation of dlPFC networks supporting sustained attention
Decreased hit rate due to reduced dlPFC engagement following nAChR stimulation
No behavioral change because acetylcholine primarily affects amygdala-mediated fear conditioning rather than attention
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. Nicotinic acetylcholine receptors (nAChRs) enhance attentional processing, particularly in prefrontal cortical networks like the dorsolateral PFC (dlPFC). In this vignette, nAChR partial agonism increases dlPFC activity and P300 amplitude during target detection. Choice B is correct because it accurately reflects how enhanced cholinergic modulation of dlPFC networks improves sustained attention, leading to increased hit rates. Choice A is incorrect because nAChR stimulation enhances, not reduces, dlPFC engagement. When analyzing cholinergic effects on attention, remember that nicotinic receptor activation typically enhances prefrontal cortical function and improves attentional performance.